Pancreatic Cancer Research

ResearcherThe Ohio State University Wexner Medical CenterActive in the last 2 years

McKenzie L. Schaefer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8147-7980; OpenAlex author ID A5122802249, A5124024607. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2026: 5 papers

Papers 5

  1. Medical and Surgical Oncologist Collaboration and Long-Term Outcomes Among Patients With Pancreatic Cancer. Co-author DOI 10.1016/j.jss.2026.06.023↗
  2. Time Toxicity and End-of-Life Treatment of Metastatic Pancreatic Cancer. First author DOI 10.1200/op-26-00413↗
  3. The Landmark Series: Mutation-Based Therapy of Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-20366-0↗
  4. ASO Visual Abstract: The Landmark Series-Mutation-Based Therapy of Pancreatic Cancer. Co-author DOI 10.1245/s10434-026-20458-x↗
  5. Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer Databas… Co-author DOI 10.14701/ahbps.25-209↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Patrick L. Quinn · 3 shared papers, 2026 · strength 1.08
  2. Aslam M. Ejaz · 3 shared papers, 2026 · strength 1.08
  3. Susan Tsai · 2 shared papers, 2026 · strength 1.00
  4. Alex B. Blair · 2 shared papers, 2026 · strength 1.00
  5. Alison Gregorian · 1 shared paper, 2026 · strength 0.32
  6. Ashish Manne · 1 shared paper, 2026 · strength 0.26
  7. Jordan M. Cloyd · 1 shared paper, 2026 · strength 0.26
  8. Timothy Michael Pawlik · 1 shared paper, 2026 · strength 0.26
  9. Mary E. Dillhoff · 1 shared paper, 2026 · strength 0.26
  10. Anne M. Noonan · 1 shared paper, 2026 · strength 0.26
  11. Laith I. Abushahin · 1 shared paper, 2026 · strength 0.26
  12. Shafia Rahman · 1 shared paper, 2026 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.